XIA Lu, WU Huan, LIU Ping, et al. Analysis on clinical efficacy and liver injury of 100 cases of COVID-19 treated by integrated traditional Chinese and western medicine. [J]. Shanghai Journal of Traditional Chinese Medicine 54(7):23-28(2020)
DOI:
XIA Lu, WU Huan, LIU Ping, et al. Analysis on clinical efficacy and liver injury of 100 cases of COVID-19 treated by integrated traditional Chinese and western medicine. [J]. Shanghai Journal of Traditional Chinese Medicine 54(7):23-28(2020) DOI: 10.16305/j.1007-1334.2020.07.095.
Analysis on clinical efficacy and liver injury of 100 cases of COVID-19 treated by integrated traditional Chinese and western medicine
Objective:To retrospectively analyze the clinical efficacy and liver injury of 100 cases of coronavirus disease 2019 (hereinafter referred to as COVID-19) treated by integrated traditional Chinese and western medicine in Shanghai. MethodsWe collected the clinical data and treatment plan of 100 cases of COVID-19 admitted to Shanghai Public Health Clinical Center from January 22,2020 to February 10,2020, observed the tongue image, pulse condition, TCM syndromes, liver injury indexes, clinical outcome and prognosis, and compared the changes of clinical symptoms, inflammation and immune related indexes. Results:①In this study, COVID-19 cases presented 3 main traditional Chinese medicine (TCM) syndromes:heat toxin blocking the lung, damp toxin stagnating the lung and qi deficiency of the lung and spleen. There were more cases of excess syndrome than cases of deficiency syndrome, and cases of the lung-spleen qi deficiency syndrome were more than cases of the dual deficiency of qi and yin syndrome. ② There were 43 asymptomatic cases (43.0%) at the time of admission. After taking TCM decoction, the main symptoms of 52 symptomatic cases, such as fever, cough, expectoration, poor appetite and diarrhea, were improved to varying degrees. ③There were significant differences in serum leukocyte count (WBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and immune index (CD4,+,) before and after 1 week of TCM decoction treatment (P,<,0.05). ④A total of 16 cases had mild liver injury before the treatment of TCM decoction. By comparing the liver function indexes before and after 1 week of TCM treatment, we found that the liver function of 2 cases recovered to normal after treatment while the other 14 cases still had mild liver injury, and there was no significant difference in liver function indexes before and after treatment (P,>,0.05). The liver function indexes of the other 84 cases were within the normal range before and after 1 week of TCM decoction treatment. ⑤In this study, 81 cases (81.0%) recovered and were discharged from hospital and 19 cases (19.0%) were still under treatment with a mortality rate of 0%. The average hospitalization duration of discharged patients was (16.0±5. 8) days. Of 5 severe cases of COVID-19,3 cases recovered from the disease and were discharged from hospital. The remaining 2 cases turned to mild type and did not develop to critical type. The conversion rate of critical case was 0%. ⑥Of 81 cases discharged from hospital, only 5 cases (6.2%) showed complete absorption of pneumonia infection, and the remaining 76 cases (93.8%) showed abnormal lesions of different degrees on chest CT. Conclusion:The integrated treatment of traditional Chinese and western medicine, especially the application of TCM decoction based on syndrome differentiation, can obviously reduce the main clinical symptoms of patients with COVID-19 such as fever, cough, poor appetite and diarrhea, etc., improve inflammatory reactions and immune imbalance of the body, reduce mortality and critical case conversion rate, and will not cause drug-induced liver injury.
关键词
新型冠状病毒肺炎新型冠状病毒中药中西医结合治疗药物性肝损伤无症状感染者结局与转归回顾性分析
Keywords
COVID-19SARS-CoV-2Chinese herbal medicineintegrated traditional Chinese and western medicine treatmentdrug-induced liver injuryasymptomatic infectionoutcome and prognosisretrospective analysis
Analysis on rules of TCM prescriptions in treating and preventing COVID-19 based on data mining
Experience of Yu Jian in treating children with SARS⁃CoV⁃2 infection——A proven critical case
Clinical study on intervention of Fuzheng Hejie Recipe in children with asymptomatic infection of SARS⁃CoV⁃2 Omicron variant
Thoughts on practice and management of clinical research of traditional Chinese medicine during normalization stage of prevention and control of COVID⁃19
Investigation on traditional Chinese medicine syndrome characteristics in patients with chronic kidney disease and infected with Omicron variant of COVID⁃19
Related Author
No data
Related Institution
Department of Prevention and Health Care of Traditional Chinese Medicine, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Experimental Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine
Department of Traditional Chinese Medicine, Fudan University of Children’s Hospital
Department of Intensive Care Unit, Fudan University of Children’s Hospital
Department of Infectious Disease, Fudan University of Children’s Hospital